Departments and specialties

Mayo Clinic has one of the largest and most experienced practices in the United States, with campuses in Arizona, Florida and Minnesota. Staff skilled in dozens of specialties work together to ensure quality care and successful recovery.

Research

Mayo Clinic doctors and scientists are studying ways to improve the diagnosis and treatment of Waldenstrom macroglobulinemia. Learn more about hematology research.

The Hematologic Malignancies Program conducts blood and bone marrow cancer research in coordination with the Mayo Clinic Cancer Center. The Mayo Clinic Cancer Center receives funding from the National Cancer Institute and is designated as a comprehensive cancer center — recognition for an institution's scientific excellence and multidisciplinary resources focused on cancer prevention, diagnosis and treatment.

Publications

See a list of publications by Mayo Clinic authors on Waldenstrom macroglobulinemia on PubMed, a service of the National Library of Medicine.

Research Profiles

Waldenstrom macroglobulinemia care at Mayo Clinic

Oct. 05, 2017
References
  1. AskMayoExpert. Waldenstrom macroglobulinemia. Rochester, Minn.: Mayo Foundation for Medical Education and Research; 2017.
  2. Waldenstrom's macroglobulinemia/lymphoplasmacytic lymphoma. Fort Washington, Pa.: National Comprehensive Cancer Network. http://www.nccn.org/professionals/physician_gls/f_guidelines.asp. Accessed June 26, 2017.
  3. Hoffman R, et al. Waldenstrom macroglobulinemia and lymphoplasmacytic lymphoma. In: Hematology: Basic Principles and Practice. 6th ed. Philadelphia, Pa.: Saunders Elsevier; 2013. https://www.clinicalkey.com. Accessed June 26, 2017.
  4. Gertz MA. Waldenstrom macroglobulinemia: 2017 update on diagnosis, risk stratification and management. American Journal of Hematology. 2017;92:209.
  5. Warner KJ. Allscripts EPSi. Mayo Clinic, Rochester, Minn. April 14, 2017.